BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11374419)

  • 1. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation.
    Neumann UP; Lang M; Moldenhauer A; Langrehr JM; Glanemann M; Kahl A; Frei U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Apr; 71(8):1163-8. PubMed ID: 11374419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of positive lymphocytotoxic crossmatch and immunosuppressive regimens in the outcome of liver transplants.
    Charco R; Vargas V; Balsells J; Lázaro JL; Murio E; Jaurrieta E; Martorell J; Margarit C
    Transplant Proc; 1997; 29(1-2):461-2. PubMed ID: 9123082
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of a positive T-lymphocytotoxic crossmatch on hepatic allograft survival and rejection.
    Bathgate AJ; McColl M; Garden OJ; Forsythe JL; Madhavan KK; Hayes PC
    Liver Transpl Surg; 1998 Jul; 4(4):280-4. PubMed ID: 9649641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreas transplantation in crossmatch-positive recipients.
    Khwaja K; Wijkstrom M; Gruessner A; Noreen H; Sutherland DE; Humar A; Kandaswamy R; Gruessner RW
    Clin Transplant; 2003 Jun; 17(3):242-8. PubMed ID: 12780675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive lymphocytotoxic crossmatch does not adversely affect survival in living donor liver transplantation.
    Sugawara Y; Tamura S; Kaneko J; Togashi J; Makuuchi M; Kokudo N
    Dig Surg; 2009 Feb; 26(6):482-6. PubMed ID: 20068321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
    Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
    Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive.
    Scornik JC; Clapp W; Patton PR; Van der Werf WJ; Hemming AW; Reed AI; Howard RJ
    Transplantation; 2001 Apr; 71(8):1098-102. PubMed ID: 11374409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined liver-kidney transplantation: long-term follow up in 18 patients.
    Lang M; Kahl A; Bechstein W; Neumann U; Knoop M; Frei U; Neuhaus P
    Transpl Int; 1998; 11 Suppl 1():S155-9. PubMed ID: 9664968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of anti-HLA antibodies and positive T-lymphocytotoxic crossmatch on survival and graft rejection in human liver transplantation.
    Charco R; Vargas V; Balsells J; Lázaro JL; Murio E; Jaurrieta E; Martorell J; Margarit C
    J Hepatol; 1996 Apr; 24(4):452-9. PubMed ID: 8738732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor-specific antibodies after transplantation by flow cytometry: relative change in fluorescence ratio most sensitive risk factor for graft survival.
    Christiaans MH; Overhof-de Roos R; Nieman F; van Hooff JP; van den Berg-Loonen EM
    Transplantation; 1998 Feb; 65(3):427-33. PubMed ID: 9484765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
    Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
    Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of a positive crossmatch in liver transplantation: a 20-year review.
    Ruiz R; Tomiyama K; Campsen J; Goldstein RM; Levy MF; McKenna GJ; Onaca N; Susskind B; Tillery GW; Klintmalm GB
    Liver Transpl; 2012 Apr; 18(4):455-60. PubMed ID: 22139972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
    Lang M; Kahl A; Bechstein WO; Neumann U; Settmacher U; Frei U; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):1865-7. PubMed ID: 9723313
    [No Abstract]   [Full Text] [Related]  

  • 16. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch.
    Stratta RJ; Mason B; Lorentzen DF; Sollinger HW; D'Alessandro AM; Pirsch JD; Kalayoglu M; Belzer FO
    Transplantation; 1989 Feb; 47(2):282-6. PubMed ID: 2645713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.
    Saidman SL; Duquesnoy RJ; Demetris AJ; McCauley J; Ramos H; Mazariegos G; Shapiro R; Starzl TE; Fung JJ
    Transpl Immunol; 1994; 2(1):61-7. PubMed ID: 8081794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft.
    Aoki T; Sugawara Y; Takahashi M; Kawaguchi Y; Kaneko J; Yamashiki N; Tamura S; Hasegawa K; Takahashi K; Kokudo N
    J Gastroenterol; 2012 Apr; 47(4):486-8. PubMed ID: 22328021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.